Related Experiment Video
Updated: Jul 5, 2025
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Vascular Endothelial Growth Factor A VEGFA Inhibition: An Effective Treatment Strategy for Psoriasis
Ya Chen1, Zongguang Tai1, Congcong Zhu1
1Shanghai Skin Disease Hospital, School of Medicine, Tongji University, 1278 Baode Road, Shanghai 200443, China.
Psoriasis involves an epithelial immune microenvironment (EIME) where blood vessel growth, regulated by vascular endothelial growth factor A (VEGFA), fuels skin inflammation. Targeting VEGFA may offer new psoriasis treatments.
Area of Science:
- Dermatology
- Immunology
- Angiogenesis Research
Background:
- Psoriasis is an immune-mediated inflammatory skin disease characterized by an epithelial immune microenvironment (EIME).
- The role of angiogenesis, or new blood vessel formation, in psoriasis pathogenesis is not fully understood.
- Vascular Endothelial Growth Factor A (VEGFA) is a critical regulator of angiogenesis and implicated in psoriasis development.
Purpose of the Study:
- To investigate the role of blood vessels in psoriasis.
- To explore the relationship between VEGFA and keratinocytes within the EIME.
- To identify potential new therapeutic strategies for psoriasis.
Main Methods:
- Analysis of VEGFA's role in promoting angiogenesis in psoriatic lesions.
- Investigation of VEGFA's direct effects on epidermal keratinocytes and immune cells.
- Review of clinical data on anti-angiogenic therapy efficacy in psoriasis.
Main Results:
- VEGFA promotes angiogenesis, supporting keratinocyte proliferation and immune cell infiltration in psoriasis.
- VEGFA levels may serve as a biomarker for disease severity and treatment response.
- Anti-angiogenic therapies have shown promise in improving psoriatic skin lesions.
Conclusions:
- Blood vessels and VEGFA play a significant, often underestimated, role in psoriasis.
- Understanding the VEGFA-keratinocyte interaction in the EIME is crucial for developing targeted therapies.
- VEGFA-targeted treatments represent a promising avenue for managing psoriasis.
More Related Videos
06:43Increased Recovery Time and Decreased LPS Administration to Study the Vagus Nerve Stimulation Mechanisms in Limited Inflammatory Responses
Published on: March 29, 2017
07:56Isolation of Intrapulmonary Artery and Smooth Muscle Cells to Investigate Vascular Responses
Published on: June 8, 2022
Related Concept Videos
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
01:24Regulation of Angiogenesis and Blood Supply